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Whole Cell Mass Spectroscopy (WCMS) is a method that has gained 
popularity in the last decade.  WCMS saves time by omitting extensive sample 
preparation for mass spectrometric analysis of microorganisms.  WCMS has 
been mainly used for profiling and identifying fungi, bacteria and mammalian 
cells.  We utilized WCMS as an assay for differentiating in vitro cellular toxicity.  
In this study we focused on using HepG2 cells, a liver carcinoma cell line, for 
WCMS profiling of untreated cells and dosed cells with known toxins.  We have 
optimized the parameters for using two different mass spectrometers and 
obtained accurate and sensitive profiling of the whole liver cells. To verify the 
toxic response at the time of WCMS, we tested our cells with the traditional 
cytotoxicity assays which included lactate dehydrogenase (LDH) or MTT 
assay(3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide).  This 
research lays down the groundwork for a technique with great applications in 
pharmacology, toxicology, and medicinal chemistry. 
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CHAPTER I 
INTRODUCTION 
 
Specific Aims 
 
Unexpected liver toxicity is one of the main causes for drug trial failure.   In 
toxicology the preliminary risk assessment of a given compound relies on in vitro 
cytotoxicity assays.  The conventional in vitro cytotoxicity assays study the 
effects of a given compound by examining the dose and time dependence to a 
model cell organism. These cytotoxicity assays present a somewhat limited 
approach to observe a systemic response, where the cell viability is measured 
based on the activity of certain proteins, enzymes, or organelles after a specific 
dosage or time exposure.  To understand the specific in vitro toxic mechanisms a 
battery of assays need to be performed. After which, the findings of in vitro 
analysis do not always correlate with the in vivo or the trial-stages of a drug 
development.  The use of whole cell mass spectrometry can accelerate the risk 
assessment process by providing a quick systemic analysis of a given xenobiotic.  
While traditional cytotoxic assays present a specific organelle or enzyme 
response which can provide limited information. 
2 
 
Nanomaterials have potential applications in the pharmaceutical, food, 
chemical and many other industries1. By 2016, the expected market demand of 
nanomaterials is $ 5.5 billion. Gold nanoparticles are of particular interest due to 
their unique physical and chemical properties. In the biomedical arena, gold 
nanoparticles have promising applications as a drug or nucleic acids delivery 
system. With respect to the chemical and physical properties, nanoparticles fall in 
a novel category in terms of their behavior. Nanoparticles behave neither like 
small molecules nor like bulk materials.   
Gold nanoparticles are easy to synthesize, and modify to meet a desired 
objective, yet this accelerates the pace in which a new compound is created. 
Toxicology risk assessments have yet to catch up with the myriad of 
nanoparticles and their potential applications.  The MTT and the lactate 
dehydrogenase assays are considered the gold standards in cytotoxicity risk 
assessment.  Gold nanoparticles can interfere with these two assays as they can 
adsorb key molecules of the assay and/or absorb or scatter specific wavelengths 
used in either of these assays depending on the gold nanoparticle used.   This 
presents the necessity for a method that does not rely on UV-absorption.   Mass 
spectrometry can bridge this gap with a rapid method that does not depend on a 
single mechanism or reagent, and can provide a whole cell assessment.  
The purpose of this research is to develop a high throughput cytotoxicity 
screening using Matrix Assisted Laser Desorption/Ionization Time of Flight Mass 
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Spectrometry (MALDI-TOF-MS).  To develop such a method we first have to 
optimize the instrument conditions, define the limits of detection, and determine 
the sample preparation method.  We used HepG2 cells, an in vitro model of liver 
carcinoma cells. We hypothesize that untreated HepG2 cells will have a unique 
mass spectral profile, which will vary after exposing cells to different toxins.  We 
expect to design a revolutionary methodology which can comprehensively 
examine the toxicological effects of gold nanoparticles and other well established 
toxins, thus speeding the risk assessment process. 
Method optimization to develop a reproducible profile of Whole HepG2 cells in 
MALDI Mass spectrometer quadrupole time of flight  
 
Obtaining a reproducible mass spectral signal from cells without a 
digestion, separation, or isolation is a difficult task due to the biochemical 
complexity of the samples. We will be loading whole cells to the mass 
spectrometer; which presents high variability within the sample.  
To achieve a high throughput method, we aim to minimize the processing 
steps of cells before the mass spectrometry analysis.  We understand that we 
could not obtain a signal with just direct raw samples for which we have to 
compromise with some sample preparation.  
We hypothesize that we can obtain a reproducible signal for signature 
mass spectra profile of intact HepG2 cells by optimizing the sample preparation 
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and acquisition protocols.  We expect to develop a standard protocol for mass 
spectra analysis of untreated HepG2 cells.   
 Study 1.1: Instrument optimization for analysis of mammalian cells 
 Study 1.2: Effects of sample preparation on cell viability and signal 
 Study 1.3: Sample matrix and loading effects on cell signal  
Whole cell mass spectrometry as a methodology to test nanomaterial and known 
toxins cytotoxicity using in vitro models 
 
We hypothesize that HepG2 cells will generate a unique mass spectra 
profile signature depending on the toxin and exposure. We will use well known 
toxins (aflatoxin B1, acetaminophen) and verify their cytotoxicity with assays like 
MTT, Lactate Dehydrogenase, and Tryptan Blue cell viability assessment.  We 
will also examine the cytotoxic effects of gold nanoparticles, whose toxicity is not 
well understood.  We expect to obtain distinct mass spectra for the well-known 
toxins, an elucidation of a potential nanoparticle toxic dose which would have not 
been achievable through the traditional toxicology screenings. 
 Study 2.1:  Evaluate cytotoxic effects of known toxins with traditional 
lactate dehydrogenase and MTT assays 
 Study 2.2:  Cross reference a novel compound (gold nanomaterials) 
effects on HepG2  
Intact cell mass spectrometry (ICMS) or whole cell mass spectrometry 
(WCMS) is an emerging field that arose in the last seventeen years.  The 
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technique was developed to identify microorganisms without the need of 
trypsination or separation by minimally preparing and directly placing an entire 
cell sample to be analyzed by a Mass Spectrometer (MS).   The use of intact cell 
mass spectrometry has become a well-established technique for microorganism 
identification2.  
Other than the use of WCMS, the traditional identification of organism 
method which uses mass spectrometry relies on generating a mass spectral 
profile (finger print) after extensive preparation where the cells have gone 
through isolation and purification techniques like trypsination which generate a 
wide array of peptides, lipids or oligonucleotides.  A selected group of masses 
measured in the mass spectrometer serve as biomarkers for identifying a given 
organism. The traditional identification approach has the drawbacks of being time 
consuming, cost restrictive and give a somewhat fractionated view.  Fractionated 
view in the sense that the sample has to be purified, or separated in some form 
prior to analysis. The interested party may lose important information of the 
sample through this purification.  
Whole cell mass spectrometry (WC-MS) analysis has been primarily used 
to identify bacteria 3-7, fungi 8, 9, and a limited extent in vivo and in vitro 
mammalian cells 2, 10-12.  In a similar manner like the conventional MS 
identification method, WCMS relies on the generation of a unique array of mass 
spectral peaks (finger print), which can be correlated to genus and species of the 
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questioned organism8.  This new identification technique has ample applications 
in the diagnostics, taxonomical, pharmaceutical and even biodefense fields13.  
For whole cell analysis, the instrument of choice tends to be the Matrix Assisted 
Laser Dissociation Induced Mass Spectrometer (MALDI MS)2, 4, 5, 7-10, 14-25.   
MALDI MS is used for several reasons, but the two main drives tend to be the 
broad mass range, and a relative salt tolerance.   
 
Figure 1.  Flow chart of the common approach taken to study cytotoxicity 
using Mass Spectrometry.  Whole cell mass spectrometry aims at 
minimizing the time and cost consuming steps of separation, lyzing or 
digestion 26. 
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In an attempt to build on the microorganism identification WC-MS 
technique we intended to branch out into the field of toxicology. We hypothesized 
that evidence of cytotoxicity can be detected using whole cell mass spectra 
analysis,  as the conventional fingerprint technique has been used to determine 
cytotoxicity in in vitro cell samples26, 27 and identification is attainable using 
WCMS based on a the conventional technique, we assume we could use this 
technique for toxicology. Our initial goal was to develop a technique which could 
ultimately be used for blind screenings as it can be seen in Figure 1.  The main 
difference between the conventional MS toxicity screening and our proposed 
method lies in the sample preparation before the MS analysis.  Our proposed 
method will not rely on the use of trypsin, chromatography or other digestive/ 
purifying methods commonly used in the conventional MS analysis Figure 1.  The 
traditional cytotoxicity screening compares masses measured from the fingerprint 
with theoretical masses and a scoring algorithm will determine the probability that 
the microorganism has been exposed to a given toxin.  If our proposed method 
would use a similar approach, it could not rely on previous theoretical masses, 
for which a new database will have to be developed. 
A dosed cell will generate a different MS profile spectra than the control 
cells which have not been dosed.  We worked under the assumption that a 
xenobiotic (foreign chemical) induces a molecular alteration in a given model cell 
organisms which we could then measure using MALDI-MS.   The molecular 
alteration mass spectra could then be stored in a database and used as a 
8 
 
reference for potential blind screenings. A cytotoxicity assay using WC-MS would 
be advantageous since it operates with a small number of cells and is cost 
effective, and high through put. 
The purpose of this research is to develop a cytotoxicity assay using 
Matrix Assisted Laser Desorption/Ionization quadrupole Time of Flight Mass 
Spectrometry (MALDI-qTOF-MS) for the detection of in vitro cytotoxicity.  This 
toxicological Whole Cell Mass Spectrometry method (TWCMS) method was 
compared with well-established cytotoxicity assays, like the (MTT) and lactate 
dehydrogenase (LDH) assays.  The advantage of using mass spectrometry (MS) 
lies in the sensitivity, resolution, type of detector and time efficiency which cannot 
be achieved through the conventional UV -absorption methods.  This research 
intends to provide the groundwork for the development of a methodology with 
potential uses in toxicology and diagnostics arena.   
The field of whole cell mass spectroscopy has had the challenge of 
obtaining reproducibility among different labs and instruments 15, 28.  The sample 
preparation also varies among labs and instruments.  Many of the whole cell1 
mass spectroscopy studies have used bacteria as their model organism 29-32, 
adherent mammalian cells present a greater challenge due to their biochemical 
complexity and their clumping nature. To obtain reproducible spectra, it is 
                                            
1 The term Intact cell mass spectroscopy is used interchangeably with whole cell mass 
spectroscopy to refer to a similar technique.  
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necessary to have a meticulous  protocol and rigid sample preparation 4. Factors 
that influence the reproducibility in the sample preparation are: type and 
concentration of MALDI matrices, the number of cells used, and the washing 
steps 31. Prior to optimizing the sample preparation steps we need to determine 
the optimal instrument conditions.  
Study 1.1: Instrument optimization for analysis of mammalian cells 
 
This research has had the opportunity to work with two MALDI-MS-TOF 
instruments. The preliminary work was done using a linear setup, while the bulk 
of the work was done with an instrument that had an orthogonal time of flight 
tube and a quadrupole in front of the analyzer.  The tandem quadrupole –time of 
flight analyzer (qTOF) with the orthogonal setup provide advantages which the 
linear mass spectrometer cannot achieve.  A qTOF setup has higher sensitivity 
and can reach a resolution of around 10000 full width half maximum (FWHM). 
The mass accuracy of the instrument is also very high reaching 5 to 10 ppm. 
Additionally qTOF allows to read a mass range up to 20000 m/z 33 p.180.  
However, despite the high efficiency provided by the orthogonal qTOF, the duty 
cycle is less than in the linear setup therefore losing some of the ions produced 
at the source 33 p.140. We tested different instrument variables in the MALDI HD 
Synapt G2 qTOF among which were sensitivity, resolution, laser intensity, and 
the quadrupole settings.  The first three were fairly straight forward, and can be 
adjusted according to the sample necessity.  Though, the quadrupole setting was 
a bit trickier to setup. 
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The quadrupole in the instrument we used for assay development is in 
front of the TOF analyzer.  This quadrupole placement was designed to improve 
the signal to noise ratio, which can present us with a challenge since the 
transmission of ions is not as broad range as in a linear setup of the 4700 MALDI 
Mass Spectrometer.  To allow a high transmission and a lower loss of ions to the 
time of flight analyzer, we did not apply the DC resolving voltage to the 
quadrupole.  The DC voltage is suppressed by using the MS acquisition mode in 
the software 34.  
To optimize the largest range of transmission we experimented with the 
quadrupole manual profile using necrotic cells, a PEG calibrant, and a control 
healthy sample. We aimed to examine which setting would provide the best 
signal and broadest ion transmission.  We systematically modified the 
quadrupole manual profile’s ramp and dwell time in order to have a broader 
range of transmission and avoid biomarker peak suppression.  Based on 
previous work on mammalian whole cell mass spectroscopy our interest mass 
range was in 1500 -20,000 Da.  This mass range hints that our biomarker peaks 
are peptides or fragmented oligonucleotides and not whole proteins. 
Study 1.2: Effects of sample preparation on mass spectra signal 
 
The sample preparation is another key element in obtaining a reproducible 
mass spectra signal.  We aimed to minimize the number of steps before loading 
the sample to the MALDI-plate to obtain a high through put analysis. We 
11 
 
recognized that placing raw samples brought too much noise in the spectrum due 
to the biochemical complexity nature of cell sample.  Therefore we had to include 
washing steps before loading our samples to the MALDI mass spectrometer.  
The purpose of the washing steps is to remove any leftover cell culture medium, 
trypsin, fetal bovine serum and salts which increase the signal to noise ratio. The 
washing-steps recommended in the literature are rinsing with 1x Phosphate 
Buffer Solution (PBSx1)11, water35, 150 mM ammonium acetate16 or a 
combination of these rinses.   
To the best of our knowledge, HepG2 intact cell or whole cell mass 
spectroscopy has not been reported in the literature, reinforcing the need to 
evaluate the washing steps, since no washing results in a noisy spectrum, while 
washing 3 times with PBSx1 followed by 3 washes with ammonium acetate 
results in 100 % cell death. Initially, we tried to minimize cell death by the 
washing steps, since we believe it would be impractical when you are trying to 
develop a cytotoxicity mass spectral assay.  Though as our worked progressed, 
we realized that having viable cells at the point of the mass spectral analysis is 
unattainable, just by the very nature of the acid matrix that destroys the integrity 
cell.  For this reason the author would recommend the disuse of the label Intact 
cell mass Spectroscopy and favor the use of whole cell mass spectroscopy, as 
both are used interchangeably in the literature.   
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The cell viability aspect is of extreme importance; since a whole cell 
toxicity mass spectral assay would is not able to determine cell viability, which is 
important in field of toxicology and cell culture in general. Rather, whole cell 
mass spectral cytotoxicity assay would be used to determine a systemic 
molecular modification brought upon by exposure to a xenobiotic.   
Cell number 
 
For any assay, method or technique it is important to know what is the 
working range. What are the upper and lower limits of detection?  In this case the 
number of cells/µL of matrix which we can measure reasonably. 
Washing Steps 
 
To test for the effect on mass spectral signal by the cell washing steps, we 
harvested HepG2 p. 4 them using trypsin, and compared using a final confluence 
of cells ranging from 580-1160 cells/µL.  To minimally rinse our cells from 
impurities we tried washing our samples in the following manner: 
 
a) Rinse with only PBSx1 (0°C) 
b) Once with PBSx1 (0°C) followed by one wash with 150 mM (0°C) 
c) Three washes with PBSx1 (0°C) followed by three washes with 150 mM 
(0°C) 
d) Once with PBSx1 (0°C) followed by three washes with 150 mM (0°C) 
e) Once with PBSx1 (0°C) followed by three washes with DI H2O (0°C) 
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Study 1.3: Sample matrix and loading effects on cell signal  
 
Matrix Selection 
 
We have to determine which MALDI matrix is optimal to obtain a 
consistent spectrum from healthy HepG2 cells.  We had narrowed it down to 
sinapinic acid and α-cyano cinnamic hydroxyl acid, the main difference between 
these two lie in the mass range for which the matrix is best suited.  If we want to 
keep the spectrum below 10,000 Da range, we work with the α-cyano matrix, 
while sinapinic acid can be used if we desire to examine larger masses.  The α-
cyano matrix has been found to be more reproducible from spectra to spectra 35. 
Loading Effects 
 
Extensive work previously been done addressing the manner in which the 
cells are loaded onto the MALDI plate and the effect this has on the 
reproducibility of the signal.  The loading method has varied among different 
research groups with techniques ranging from the mix-volume method 11, dried-
droplet deposition, sandwich method 2 or the use of slightly more sophisticated 
instrumentation like a nebulizers 35 to load to the plate.  Each variation of the 
method is intended to optimize matrix/sample crystallization which would enable 
ionization of the large molecules for the mass spec analysis.    
Due to the extensive research in the MALDI loading technique we did not 
dove into exploring what the optimal sample loading technique on the MALDI 
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plate.  We did quickly dabble with the sandwich and the dry droplet techniques.  
Neither of these two techniques produced any positive significant differences 
among them, for which we stuck to the mixed method technique for our protocol. 
Overriding the cell detachment or trypsination 
 
One of the goals of this project was to develop a high through put assay.  
The whole cell assay sample preparation was not as time consuming like SDS 
PAGE or other separation techniques; yet, it was still taking us 6 hours of sample 
preparation.  The extensive manipulation along the way of preparing the sample 
made the procedure highly prone to human or methodological errors.  To 
minimize the error exposure and time requirement, we experimented with an 
ambitious protocol modification overriding the cell detachment and centrifugation 
steps of the initial sample preparation.  The comparison of the initial and modified 
sample preparation protocols can be observed in Figure 2 and Figure 3 
respectively.  We aimed to minimize human manipulation of the samples and 
reduce the time required to prepare the samples. 
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Figure 2. Flow chart of the initial sample preparation for TWCMS.  This 
initial method required harvesting the cells from the well plate, and several 
steps of washing, centrifuging, decanting and re-suspending. 
 
 
 
 
Figure 3.  Improved sample preparation method,which skipped the 
detaching and centrifugation steps. 
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Aim 2: Whole cell mass spectrometry as a methodology to test nanomaterial and 
known toxins cytotoxicity using in vitro models 
 
The liver is an important organ in the activation, metabolism and 
elimination of any given compound entering the human body.  The detoxification 
or intoxication is a result of the xenobiotic interaction with the iso-enzyme family 
of cytochrome P 450 36, 37.  We chose to study liver toxicity since unexpected 
hepatotoxicity frequently halts drug development during first trials 26.   
For this study we chose to work mainly with HepG2 cells, a cancerous 
immortalized cell line originally from hepatocellular carcinoma disease of a 
fifteen-year-old patient.  We were using cancerous cells as a basic model for the 
development of the methodology; once the methodology is developed and shown 
to be robust we will apply it towards noncancerous cells.  Though, the use of 
cancerous cells can highlight potential cancer treating compounds 38.  
Our first aim was to establish the protocol for the whole cell mass spectral 
analysis.  Once we determined what the steps were, we continued to see if we 
could detect cytotoxicity using this MS technique.  To do so, we needed 
reference compounds which would induce toxicity on our cell model to later be 
analyzed using the MALDI qTOF.   
The poison is in the dose, everything is toxic. This is the fundamental 
axiom of toxicology where any xenobiotic (foreign chemical) can have detrimental 
effects depending on the concentration, dosage or exposure.  Different kinds of 
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chemicals will produce different kinds of toxic responses.  There are xenobiotics 
that can have more than one type of toxic response.  The fundamental question 
on our research is if we can detect or notice a difference between the mass 
spectral profiles of a control cell versus cells that have been exposed to a 
chemical at a toxic dose. 
To determine whether or not we are administering a toxic dose to our cell 
organisms we used cell viability assays.  To determine cell viability we primarily 
used the MTT assay; we also used the LDH and tryptan blue cell viability assay. 
LDH seemed appealing since the measurements can go in parallel with the MS 
and the MTT measurements, and both procedures decant the medium as an 
initial step.  Though the LDH was disfavored due to time demand and it has been 
reported that nanoparticles can interfere with the LDH stability.   The LDH assay, 
an enzymatic reaction monitored through UV, might not be suitable for a 
toxicology analysis of compounds from the emerging field nanoscience 39.  
Study 2.1:  Evaluate cytotoxic effects of reference toxins with MTT and LDH 
assays 
 
We aimed to use whole cells in our TWCMS analysis, reducing the 
processing time compared to other MS based cytotoxicity screenings.  We 
expected to obtain unique toxicological mass spectral profile for each type of 
cellular response to any given xenobiotic. An approach inspired by the method 
which uses mass spectrometry for microorganism identification.  Mass 
spectrometry microorganism identification relies on specific proteins, peptides, 
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oligonucleotides or lipids peaks to generate a unique mass spectra profile. A 
handful of these peaks are used as biomarkers and stored in a database.   
The aim of doing whole cell MS analysis is to minimize the preparation 
time, and still obtain specific protein biomarker peaks without the need of the 
arduous sample preparation.  Using the digestion approach, research has shown 
unique toxicological cellular responses represented through biomarker peaks 
from multiple drugs on HepG2 cell lines 26.  In the same manner, as intact cell 
mass spectroscopy microorganisms identification arose from models which used 
digestions or separations, we aim to obtain toxicity biomarkers peaks from 
HepG2 with intact cell mass spectroscopy.  Whole cell or intact cell MS analysis 
is the technique on which we will base our toxicity method.  
The use of intact cells or whole cell analysis as a toxicological tool has 
only been approached by Dong et. all 2011, who claimed they were able to 
differentiate apoptotic cells from healthy cells. 11, 40. Dong et. al. 2011 had a high 
level of reproducibility and claimed to be the most rapid approach towards the 
detection of apoptosis in mammalian cells.  The aforementioned study was 
correlate the advent chemically induced apoptosis (programed cell death) with 
the expression of unique MALDI TOF MS peaks 11.  This paper was ground 
breaking since early development of the WCMS field, researchers claimed that 
the detection of virulence or toxicity would not be possible using WCMS 
analysis15.   
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Despite the innovative approach of Dong’s group, we would disagree that 
what they observed was specifically the event of apoptosis. Dong et all claimed 
they were unable to distinguish between necrosis and healthy cells, where they 
induced necrosis to HeLa cells by physical disruption through freezing and 
sonication.  The group was able to distinguish apoptosis, after incubating the 
cells for twenty four hours with apoptposcamptothecin, etoposide, and 
andrographolide.  These three chemicals are known to induce apoptosis and 
were confirmed of doing so by flow cytometry.  Our disagreement stems in that 
Dong was measuring the systemic molecular alteration after exposure to the 
chemical rather than having a technique which measures apoptotic versus 
healthy cells.  This group did not use chemical to cause necrosis, and were 
unable to distinguish between the healthy cells, while for each of the apoptotic 
inducing chemicals had a slightly different mass spec profile.  Therefore the 
difference that they were measuring was either the ultimate toxicant, or the 
modified molecular target, and not a symptom of apoptosis. 
The idea of the molecular alteration has been presented frequently 
throughout this document as we aimed to show that exposure to different 
chemicals will have a response which we can detect through different mass 
spectra profiles. We aim to use the MALDI- qTOF-MS to detect healthy HepG2 
cells from cells going through different toxic cellular responses produced by the 
exposure to different chemicals.  This work will potentially lay the ground for the 
development of an MS toxicity-response database, which can be used for a quick 
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toxicity screening of any given compound being developed.  Though, for the 
development of such a database it is necessary to have an agreement of a 
rigorous protocol for sample preparation and analysis among different labs and 
for each cell line.  This might be unpractical or even unfeasible, nevertheless this 
technique could be used as an accompanying method for toxicologists who are 
trying to assess molecular responses on a given organism.  
MTT assay 
 
The MTT assay is considered an in vitro toxicity gold standard for the 
screening of a compounds effect on the cell viability.  The MTT is colorimetric 
assay that was developed by Tim Mossman in 1983 41.  The assay is based on 
the UV absorbance of the formazan crystals at wavelengths of around 570 nm.  
MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) reacts only 
with living cells, since only living mitochondria has the necessary mithocondrial 
reductase which cleaves tetrazolium ring into an insoluble formazan crystal 
(Figure 4).  41 
 
 
Figure 4. Example of a plate with HepG2 cells which have been incubated 
with MTT solution. 
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To evaluate the working range of the MTT we performed serial dilutions of 
cell into the wells in a 48-well plate.  The upper limit of cells can be adjusted 
accordingly with the volume or concentration of the MTT solution.  The minimal 
amount of cells we needed for a consistent reading was 10,000 cells per well 
(Figure 5).  When dealing with an expensive cell line or very low number of cells, 
the MTT assay can be restrictive to evaluate cytotoxicity.  As it will be further 
presented, the MS assay we are developing works with very few cells 
highlighting one of the advantages this alternative MS assay. 
The MTT is a reliable assay for measuring in vitro cell viability, though this 
assay is challenged by the other factors besides the low cell number previously 
mentioned. One limitation is that the assay correlates cell viability with 
mitochondrial reductase activity.  Where a given compound can solely inactivate 
or enhance the mitochondrial activity and the plate reading will be interpreted as 
cell viability or increase 42.  A second limitation lies in the physical/optical 
properties of the compound been screened, as they can interfere with the plate 
reader since they can absorb at wavelengths also ranging from 500-600 nm.   43, 
44.   
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Figure 5. Calibration of the MTT assay in 48 well plate. 
 
 
LDH assay 
 
The lactate dehydrogenase (LDH) assay is based on the change in 
absorbance of the LDH catalyzed reduction of NADH to β-nicotinamide adenine 
dinucleotide (NAD+).  Most damaged eukaryotic cells release extracellular LDH 
42. Therefore the LDH activity  can be used as a cytotoxic indicator, this activity 
can be measured through the change in absorbance of NADH at 340 nm 39.   
Some nanoparticles can interfere with the LDH stability, for which the LDH might 
not be suitable for a toxicology analysis of compounds from this emerging field 39.  
To perform the LDH assay it is necessary to have the pyruvate and NADH 
as reagents.  The assay is a kinetic assay which studies the reduction to β-
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nicotinamide adenine dinucleotide, where lactate dehydrogenase is the catalyst 
of this reduction. Using a UV spectrophotometer the reduction rate can be 
quantified. The reduction-rate ratio between of the dose and control cells are 
compared giving the percentage of LDH that was released. 
 
LactateNADPyruvateNADH LDH  
 
Study 2.2:  Cross reference a novel compound (gold nanomaterials) effects on 
HepG2  
 
To examine the method developed we experimented using a compound 
which has commonly been referred to as nontoxic due to its inert nature, this 
compound is gold nanoparticle.  We hypothesized that we would be able to 
detect signs of toxicity at lower doses than what traditional methods like MTT and 
LDH are able to detect.  We used gold nanoparticles with an average size of 12 
nm, enabling physical endocytosis44 and potentially triggering toxic pathways. 
Some nanomaterials like carbon nanotubes have shown to interfere with this 
assay 43, reinforcing the necessity for an alternative rapid method for screening 
nanomaterials. 
  
24 
 
Gold Nanoparticles  
 
 Nanoparticles (NP) have promising uses in therapy and diagnosis, 
cosmetic and food industry. NP can be used as delivery agents for drugs or 
nucleic acids inside the cells. Gold nanoparticles (AuNP) have a lot of potential 
applications since they are easy to make, chemically stable, and have unique 
optical properties 44. Despite the promising uses of nanoparticles,  the 
toxicological effects on humans and the environment remains relatively unknown 
44, 45. 
An important element in the development of this new MALDI-TOF-MS 
toxicity method lies in the optical properties of gold nanoparticles.  Gold 
nanoparticles can scatter light in the visible spectrum at varying wavelengths 
depending on their physical characteristics 46  they can also interfere with 
fluorescence, or light absorbance based assays such as the LDH and the MTT.   
Additionally, gold nanoparticles can adsorb molecules from the cell medium 
involved in the redox reactions of the traditional cytotoxic assays 44   
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CHAPTER II 
CHEMICALS AND METHODS 
 
Cell Culture 
 
HepG2 cell line was obtained from ATCC.  The cells were thawed from a 
liquid nitrogen container, and suspended in 12 mL of Dulbelcos Eagle Medium 
(37°C) with 10 % Fetal Bovine Serum and Penicillin Strip.  The cell suspension 
was then transferred to 75 cm2 incubation flask.  The cell flask was incubated at 
37°C and 5% CO2.  The medium was changed twice per week.  When cells 
reached a confluence of <90% they were subcultured into 3 incubation flasks or 
well plates corresponding to the experiment on hand.  
Subculturing the cells 
 
At 95 % confluence cells were subcultured, into further flasks or well 
plates.  The flasks were decanted from medium washed using PBSx1 at 37°C.   
MALDI solutions 
 
TFA ( 0.1%) 
Decanted 10 µL of triflouroacetic acid (Fluka 91703) into 10 mL volumetric 
flask (Pyrex A), diluted to 10 mL with DI H2O.
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Chemicals  
 
1:1 (ACN: 0.1 % TFA)  
 
Mixed 5 mL of acetonitrile (Fisher Biotech Lot. no. 024930 with 5 mL of 
TFA (0.1% 
Sinapinic acid matrix  
 
Weighed 0.010 g of sinapinic acid (Fluka 85429), diluted it in 1 mL of 1:1 
ACN:0.1 %TFA.  The solution was filtered through a 0.22 µm filter. 
CHCA matrix  
 
Weighed 0.0122 g of α-cyano-4-hydroxycinnamic acid (Fluka 70990), 
diluted it in 1 mL of 1:1 ACN:0.1 %TFA.  The solution was filtered through a 0.22 
µm filter. 
150 mM ammonium acetate  
 
Weighed 0.1137 g of ammonium acetate (Fluka 09688), diluted it in 10 mL 
of DI H2O. 
PEG MALDI calibration standard   
 
This mixture was formulated and provided by Triad Mass Spec Facility.  
Each stock was diluted to 10mg/mL (in 1:1 Water:ACN), 10 µL of 1000 PEG, 10 
µL of 2000 PEG, 20 µL of 3000 PEG, 40 µL of 4000 PEG, 60 µL of 6000 PEG, 
60 µL of 8000 PEG, plus 30 µL of 2 mg/mL NaI (in 1:1 Water:ACN).  
 
 
27 
 
MALDI Protocol 
 
The goal is to have between 500-1000 cells / µL of Matrix on the target 
MALDI plate.  Preferably the sample should not have cell agglomeration, and 
wash the cells accordingly to remove the salts from the medium.   
Sample washing 
 
 
1. Harvest cells using trypsin EDTA 0.05 % 
2. Centrifuge harvested cells at 1000 RPM (4 °C, 5-10 min).  From this step 
on you should keep the sample and solutions in ice bath or 0°C. 
3. Count cells using Hepatocytometer 
4. Transfer one million cells to start the washing process. 
5. Wash cells and re-suspend with 1xPBS, centrifuge 1000 RPM, repeat 
twice 
6. Wash cells and re-suspend with 150 mM ammonium acetate, centrifuge 
1000 RPM, repeat twice 
7. Decant solution and re-suspend in the matrix, serial dilution  Performing 
another cell count is advisable since cells might have been discarded in 
the washing process. 
8. Load 0.5-1 µL to the MALDI plate, preferably with α-CHCA matrix. 
 
 
MTT assay 
 
The supernatant medium of the wells was decanted and replaced with 
medium containing the MTT solution and minimal fetal bovine serum. We 
incubated for two to four hours after which we decanted the medium containing 
the MTT solution. The purple formazan can be seen at the bottom of the well 
plates Figure 4.  The purple formazan is diluted with a strong organic solvent or 
detergent. The UV absorbance readings with a Gen5 plate reader at 570 nm.  
The control well absorbance value serves as a reference for the dosed samples.   
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CHAPTER III 
AIM 1: METHOD OPTIMIZATION TO DEVELOP A REPRODUCIBLE PROFILE 
OF WHOLE HEPG2 CELLS IN MALDI MASS SPECTROMETER 
QUADRUPOLE TIME OF FLIGHT 
 
Results of Study 1.1 
 
The manual setting on the quadrupole profile has the following input 
variables: 
 
Table 1. Represents the input table in the tune page software to setup the 
manual quadrupole profile options found in the instrument software of the 
MALDI-qTOF synapt G2.  These numbers are the ones that gave us the 
broadest ion transmission. 
 
Mass  Dwell Time (% 
Scan Time) 
Ramp Time (% 
Scan Time) 
1. 1000 5 15 
2. 4000 55 25 
3. 8000   
 
 
As we can see in Figure 6, the ions will shift depending on the quadrupole 
profile.  The three spectra were taken from the same spot/sample of a HepG2 
sample.   When setting up the quad profile the mass entry is of primordial 
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importance. The auto quad profile tends to favor the masses below 3000 Da.  We 
aimed at having a transmission between 1500 and 20000 Da, therefore the auto 
quadrupole profile would not be favorable.  We tried to promote masses above 
3000 Da by making the minimal mass be 3000 Da (top spectra).  We did get a 
better transmission of the higher mass ions though the ion suppression is too 
drastic for the masses below 3000 Da.  Maximizing the second mass (bottom 
spectra) on the input table had similar ion transmission and suppression as in the 
auto quad profile.    
To further evaluate the ion transmission and suppression of the 
quadrupole configuration, we experimented using a polyethylene glycol (PEG) 
standard.  An example of these experimentations for ion transmission can be 
seen in Figure 7.  The PEG MALDI calibration mix was a formulation of multiple 
standards with masses ranging from 1000 up to 8000 Da.  Figure 7, shows the 
suppression of ions greater than 4500 by having the maximum mass be 4500 
Da. 
As we systematically analyzed the different input parameters of the 
manual profile we found the broadest ion transmission for mass range of 1000-
15000 Da with the configuration presented in Table 1.  The maximum mass that 
can be entered is 8000 Da, and this configuration was found favorable both in the 
cell and PEG analysis.  
 
 
 
Figure 6.  HepG2 MS spectra. The three spectra show the effect of the quad profile on ion transmission and 
suppression on the same MALDI spot.  
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Figure 7. PEG calibrant collected with the quadrupole profile described in Table 1.
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Results of Washing Steps 
 
The number of cells will determine firstly whether there is a signal from the 
mass spec.  Yet, we found that rinsing with Ammonium Acetate improves the 
signal to noise ratio of the spectra.  In some cases the peak with the highest 
relative abundance will shift as seen in Figure 8.  Where a spectra on top was 
washed Once with PBSx1 (4°C) followed by three washes with DI H2O (4°C), and 
the one on the bottom was washed with PBSx1 (4°C) followed by three washes 
with 150 mM (4°C).  We can observe that the highest intensity peaks are around 
2331 when washed with H2O though the highest intensity was at 4337 Da when 
washed with ammonium acetate.  The signal to noise ratio significantly improves 
when the cells are rinsed with ammonium acetate for salt removal. Figure 9 
highlights the importance of the ammonium acetate wash as we can see a 
significant amount of noise with samples only washed once with 150 mM 
ammonium acetate after an initial PBS wash. 
Though you can obtain a reproducible spectrum by washing the cell 
samples with H2O and PBS, ammonium acetate provided better noise reduction.  
Despite our systematic analysis, the washing is not the limiting factor to get a 
signal, which has allowed a variety in the protocols for sample-preparation 
throughout the literature.
 
 
 
Figure 8.  Comparison of the washing effect on the sample.  The top spec was washed with DI H2O after a 
preliminary wash with PBSx1.  Bottom spec was washed with 150 mM ammonium acetate after a 
preliminary wash with PBSx1. 
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Figure 9. WCMS of HepG2 cells.  Samples were washed once with PBSx1 followed by once with 150 mM 
Ammonium Acetate.
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Experimental Setup for Cell Number 
 
To test the limit of detection we made serial dilutions from with either SA 
or α-CHCA MALDI matrix cell stock.  The initial cell stock had 3x102 cells/µL, and 
was diluted down to 5x102 cells/µL. 
Results of Cell Number experimentation 
 
We found that the working cell number range for whole cell mass spectral 
analysis was 5.8x102 cells/µL up to 1.2x103 cells/µL as it can be seeing in Figure 
10.  Figure 11 shows the spectra of three different spots of HepG2, the 
confluence was of 5x102 cells/µL and suspended in α-CHCA MALDI matrix.  
Figure 11 shows the high reproducibility of this technique. To the best of the 
knowledge of the author, this is the first whole cell mass spec profile of HepG2 
cells, and the first whole cell analysis performed on a MALDI-qTOF with an 
orthogonal TOF tube. 
Obtaining the profile of the HepG2 was our eureka moment, we were very 
pleased with the results.  Though, the sample preparation to obtain such a profile 
was still consuming close to six hours of bench work to finally analyze the 
samples.  Part of our research objective was to develop a high through put 
assessment, which motivated us to make the protocol modification in our sample 
preparation. 
36 
 
 
Figure 10.  HepG2 WCMS in α-CHCA matrix. 
580 cells/µL 
1160 cells/µL 
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Figure 11.  The mass spectra profile of whole cell of HepG2 in the MALDI 
qTOF 
 
 
Experimental Setup 1.3 
 
We will ran experiments in parallel with untreated HepG2 cell lines to 
examine which matrix and sample deposition results produces the most 
consistent profile. 
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Results of Study 1.3 
 
For the linear MALDI TOF we found better results using the SA matrix 
finding some reoccurring peaks above the 10000 Da.  For the MALDI qTOF we 
found that the α-cyano matrix to give us the best results in trying to obtain a 
reproducible spectrum. 
Experimental Setup of overriding the cell detachment or trypsination 
 
To test if we could obtain reproducible spectra from whole cell analysis we 
worked with cells that were cultured in well plates.  After decanting the growth 
media from the well, instead of removing the cells from the well plate using warm 
trypsin for eight minutes, we performed the washing steps directly with the cells 
still attached.  To finally add the volume of matrix necessary for to obtain the 
working cell confluence range previously described.  
Results of overriding the cell detachment or trypsination 
 
To our satisfaction, performing the washes directly from the well plate 
allowed for reproducible whole cell spectra profile.  The spectra generated from 
the direct well plate analysis produced similar peaks to the ones generated after 
extensive washing procedure as it can be seeing in Figure 12.   
This improvement in the technique can have great repercussions in the 
field of whole cell mass spectroscopy, and facilitate its transition to be used as a 
tool for toxicity screenings.  This protocol modification has the advantages of 
saving time and minimizing error susceptibility to error by the reducing the steps.  
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The disadvantage that this modification brings an increase in cost as more matrix 
may be necessary to achieve right cell confluence. 
The trypsination and centrifugation steps take up to two hours per sample 
to prepare.  This can be significantly increased if dealing with multiple samples. 
While the washing steps directly from the plate reduces the time significantly as 
the washing is done without the need of centrifugation, therefore saving ten 
minutes per washing step.  Additionally, it is more time efficient dealing with a 
multi-well plate than with capped centrifuge tubes. 
Directly washing in the well plates allows the cells will remain adhered to 
the plate until the addition of the matrix.  Since the cells remain attach to the 
plate surface, the washing solutions can have a greater contact with the cells to 
remove impurities.  Where the in the previous procedure the centrifugation step 
clumps the cells together and the researcher had to manually re-suspend to 
guaranty an appropriate washing. During the re-suspension step cells were 
frequently lost by adhering to the pipette tip or decanting of the previous washing 
solution.  
It is worth noting that the direct plate analysis technique presented 
indications of storability, as the spectrum presented in Figure 12 was loaded the 
day after the washing steps. Storability can be achieved by allowing the matrix to 
crystalize in the well plate and storing it away from the light, to later be dissolved 
with minimal matrix and loaded to the well plate.  
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Figure 12 represents the combined spectra of multiple spot analysis of a 
samples prepared under similar condition and final cell confluence.  As we can 
observe the spectra obtain without the use of centrifugation has less noise than 
the one that went through trypsination and centrifugation.  The greater noise 
found in the bottom spectrum can be a result of human error or the exposure to 
the highly biochemically reactive trypsin. 
 
 
Figure 12.  The two mass spectra profile represent different techniques of 
sample preparation.  The top spectrum did not have the cells go through 
trypsination, while the bottom spectrum did use trypsin to detach the cells 
for further washing.
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CHAPTER IV 
AIM 2: WHOLE CELL MASS SPECTROMETRY AS A METHODOLOGY TO 
TEST NANOMATERIAL AND KNOWN TOXINS CYTOTOXICITY USING IN 
VITRO MODELS 
 
Experimental Setup of Study 2.1 
 
We address the gold nanomaterial in the study 2.2.  For our reference 
toxins we have chosen to work with aflatoxin B1 (AFB1), acetaminophen, and 
hydrogen peroxide.  Other compounds were examined, though the toxicity 
screenings did not show an reduction in cell viability. 
Results 
 
After a dose dependent MTT assay we selected to use 400 µM of AFB1 to 
be screened in the MS analysis as it can be seen in Figure 14.  Our MTT 
analysis showed robust results from the AFB1 dosage to compare with the Mass 
Spectrometry, and LDH.  We were able to optimize the conditions for working 
with HepG2 cell line and the MTT.  HepG2 showed resistance to a several 
compounds during our preliminary screenings (data not shown).   For example, 
hydrogen peroxide did not show toxicity up to the 5 mM concentration Figure 13, 
higher than what was reported in the literature 47-49. Acetaminophen showed a 
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reduction in 78 % cell viability at 30 mM (Figure 15), though for MS analysis we 
increased the dosage to 60 mM.  We were unable to obtain conclusive result 
from the MTT for the analysis of hydrogen peroxide for which we went with the 
LDH assay. 
In our whole cell analysis we were able to detect a difference in the mass 
profile between healthy cells and ones dosed with AFB1 and hydrogen peroxide 
as it can be seen in Figure 17.  Though for acetaminophen we were unable to 
detect a difference in the mass spectra between healthy and dosed cells.  
 
 
 
Figure 13. % LDH leakage of HepG2 cell lines in supernatant medium. 
ANOVA analysis gave a P<0.01, *= T-test with a P<0.01.  Error bars 
Standard Errors.  Measurement done in duplicates, with n=4.  
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Figure 14. Varying dosage of AFB1 after 24 h. ANOVA analysis gave a 
P<0.01, *= T-test with a P<0.01.  Error bars Standard Errors.  Measurement 
done in duplicates, with n=8.  We decided to go with 400 uM as an 
appropriate dosage for the MS measurements. 
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Figure 15.  MTT analysis of Acetaminophen, for MS screening we doubled 
the dose to 60 mM. ANOVA analysis gave a P<0.01, *= T-test with a P<0.01.  
Error bars Standard Errors.  Measurement done in duplicates, with n=10. 
 
 
 
Figure 16. MS analysis of HepG2  dosage after 24 h  incubation with 60 mM 
acetaminophen. 
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Figure 17. shows a response to different toxins though at a very low signal.  
This sample was collected with 4700 MALDI TOF from Applied Biosystems.  
Top Spectra are control HepG2 cells with no dose. Middle spectra-is the 
AFB1 dose, and bottom spectra-is a Hydrogen Peroxide. 
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Results of 2.2 
 
We were able to detect a difference in spectra with TWCMS as it can be 
seen in Figure 18 from the dosage of the Gold nanoparticles.  Though, as we 
suspected the traditional cell viability assay were inconclusive for HepG2 (Figure 
19) in their results as the cell did not have a dose response to GNP.  The author 
believes this is a result of the optical properties of GNP. We experimented with a 
different cell line, and we also did not obtain a dose response (Figure 21) as it 
would be expected with most xenobiotics. These results highlight the importance 
of alternate toxicity screening methods to evaluate the toxicity of new compounds 
like nanomaterials.  
From the MS results we were unable to distinguish between 75 µM and 
150 µM dosage, though we were able to differentiate from the control sample. 
The MTT analysis after 24 and 48 hour incubation did not give us a dose 
dependent response as we would expect.  This intrigued us, leading us to test a 
different cell line model. We tested the dose dependence MTT assay with A10 
cell lines, and they also did not present a dose dependent response to the GNP. 
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Figure 18. HepG2 TWCMS control and dosed with GNP 
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Figure 19.  HepG2 MTT analysis to GNP dosage. These two results 
represent the HepG2 MTT assay after 24 and 48h dosage with Gold 
nanoparticles.  These results do not present the expected dose response. 
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Figure 20.  Comparison of the doses.  From top to bottom, control, 30 mM acetaminophen, 75 uM GNP, and 
150 uM GNP. 
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Figure 21. MTT analysis on A10 cells after GNP dosage. 
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CHAPTER V  
DISSCUSSION AND FUTURE DIRECTIONS 
 
Throughout our work we were able to develop the protocol for evaluating 
whole cells for HepG2 using MALDI qTOF MS.  An improvement on previous 
whole cell analysis, since orthogonal time of flight analyzer have yet to presented 
on previous work, nor HepG2 analysis had been presented.  A major 
improvement on whole analysis was performed by overriding the centrifugation 
and harvesting steps presented in most whole cell analysis.  This improvement 
will accelerate the high through put capabilities of this type of analysis.  
 A key element for whole cell analysis has been that the cell integrity has 
to be disrupted in order to get a reproducible signal in the mass spectrometer.  
Our attempts to analyze viable cells were fruitless.  We were only able to obtain 
an MS profile after freezing or prolonged time with acidic MALDI matrix. For this 
reason the author discourages the use of the terminology intact cell mass 
spectroscopy for this type of assays.  
We were able to detect a difference in mass spectral profile with GNP 
when we were unable to obtain conclusive results from traditional cell viability 
assays.   This capability of detecting difference among GNP dosage highlights 
the importance of the method for the emerging field of nanoscience. 
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To continue on our work, the standardized protocol should be examined 
with wider array of compounds and be executed in parallel with proteomic work 
to determine what the peaks are representing. 
53 
 
REFERENCES 
 
1.  L. Wood, Research and Markets: Growth in Global Nanomaterials Market 2011‐2016, 
Trend, Forecast and Opportunity Analysis, Accessed 7/15/13, 2013. 
2.  B. Munteanu, C. Reitzenstein, G. Hänsch, B. Meyer and C. Hopf, Analytical and 
Bioanalytical Chemistry, 2012, 404, 2277‐2286. 
3.  T. Krishnamurthy, P. L. Ross and U. Rajamani, Rapid Communications in Mass 
Spectrometry, 1996, 10, 883‐888. 
4.  R. Arnold, J. Karty, Ellington, Ellington and J. Reilly, 1999, 1‐7. 
5.  T. L. Williams, D. Andrzejewski, J. O. Lay and S. M. Musser, Journal of the American 
Society for Mass Spectrometry, 2003, 14, 342‐351. 
6.  P. Chen, Y. Lu and P. B. Harrington, Analytical Chemistry, 2008, 80, 1474‐1481. 
7.  O. Sedo, I. Sedlacek and Z. Zdrahal, Mass Spectrometry Reviews, 2011, 30, 417‐434. 
8.  T. Maier and M. Kostrzewa, Chimica Oggi‐Chemistry Today, 2007, 25, 68‐71. 
9.  P. A. C. Braga, A. Tata, V. G. dos Santos, J. R. Barreiro, N. V. Schwab, M. V. dos Santos, M. 
N. Eberlin and C. R. Ferreira, Rsc Advances, 2013, 3, 994‐1008. 
10.  J. Bergquist, Chromatographia, 1999, 49, S41‐S48. 
11.  H. Dong, W. Shen, M. Cheung, Y. Liang, H. Cheung, G. Allmaier, O. Au and Y. Lam, The 
Analyst, 2011, 136, 1‐9. 
12.  J. Hanrieder, G. Wicher, J. Bergquist, M. Andersson and Å. Fex‐Svenningsen, Analytical & 
Bioanalytical Chemistry, 2011, 401, 135‐147. 
13.  P. Demirev, A. Laboratory, C. Fenselau and D. Biochemistry, Journal of Mass 
Spectrometry, 2008, 43, 1441‐1457. 
14.  H. T. Feng, L. C. Sim, C. Wan, N. S. C. Wong and Y. S. Yang, Rapid Communications in 
Mass Spectrometry, 2011, 25, 1407‐1412. 
15.  C. Fenselau, C. Maryland and P. Demirev, Mass Spectrometry Reviews, 2001, 20, 1‐15.
54 
 
16.  J. Hanrieder, G. Wicher, J. Bergquist, M. Andersson and A. Fex‐Svenningsen, Analytical 
and bioanalytical chemistry, 2011, 401, 135‐147. 
17.  Y. P. Ho and P. M. Reddy, Mass Spectrometry Reviews, 2011, 30, 1203‐1224. 
18.  L. Karamonova, P. Junkova, D. Mihalova, B. Javurkova, L. Fukal, P. Rauch and M. 
Blazkova, Rapid Communications in Mass Spectrometry, 2013, 27, 409‐418. 
19.  T. Krishnamurthy and P. L. Ross, Rapid Communications in Mass Spectrometry, 1996, 10, 
1992‐1996. 
20.  M. J. Kulkarni, V. P. Vinod, P. K. Umasankar, M. S. Patole and M. Rao, Rapid 
Communications in Mass Spectrometry, 2006, 20, 2769‐2772. 
21.  L. J. Li, R. W. Garden and J. V. Sweedler, Trends in Biotechnology, 2000, 18, 151‐160. 
22.  L. F. Marvin‐Guy, P. Duncan, S. Wagniere, N. Antille, N. Porta, M. Affolter and M. 
Kussmann, Rapid Communications in Mass Spectrometry, 2008, 22, 1099‐1108. 
23.  G. M. Toh‐Boyo, S. S. Wulff and F. Basile, Analytical Chemistry, 2012, 84, 9971‐9980. 
24.  J. Wang, W. F. Chen and Q. X. Li, Analytica Chimica Acta, 2012, 716, 133‐137. 
25.  X. Zhang, M. Scalf, T. W. Berggren, M. S. Westphall and L. M. Smith, Journal of the 
American Society for Mass Spectrometry, 2006, 17, 490‐499. 
26.  A. Van Summeren, A. Summeren, J. Renes, F. G. Bouwman, J. P. Noben, J. Delft, J. C. S. 
Kleinjans, E. C. M. Mariman and J. H. M. van Delft, Toxicological Sciences, 2011, 120, 
109‐122. 
27.  Pinnacle, B. Wetmore and B. Merrick, Toxicologic Pathology, 2004, 32, 619‐642. 
28.  P. Demirev and C. Fenselau, Annual Review of Analytical Chemistry, 2008, 1, 1‐23. 
29.  L. Baar, FEMS Microbiology Reviews, 2000, 24, 193‐219. 
30.  T. Krishnamurthy, U. Research and P. Ross, Rapid Communications in Mass 
Spectrometry, 10, 1992‐1996. 
31.  T. Williams, D. Andrzejewski, J. Lay and S. Musser, Journal of the American Society for 
Mass Spectrometry, 2003, 14, 1‐10. 
32.  Ramirez, acs.org, 1‐4. 
33.  V. Stroobant and E. d. Hoffmann, Mass Spectrometry: Principles and Applications,, 
2007. 
55 
 
34.  Waters SYNAPT G2‐S HDMS Mass Spectrometer.  Operator's Overview and Maintenace 
Guide., Waters: The science of what's possible, 2011. 
35.  G. M. Toh‐Boyo, S. S. Wulff and F. Basile, Anal Chem, 2012. 
36.  Q. Chen and A. Cederbaum, Molecular Pharmacology, 1998, 53, 639‐648. 
37.  I. Waziers, P. Cugnenc, C. Yang, J. Leroux and P. Beaune, Journal of Pharmacology and 
Experimental Therapeutics, 1990, 253, 387‐394. 
38.  B. Marquis, S. Love, K. Braun and C. Haynes, The Analyst, 2009, 134, 425. 
39.  X. Han, R. Gelein, N. Corson, P. Wade‐Mercer, J. Jiang, P. Biswas, J. N. Finkelstein, A. 
Elder and G. Oberdörster, Toxicology, 2011, 287, 99‐104. 
40.  J. Walker, A. Fox, V. Edwards‐Jones and D. Gordon, Journal of Microbiological Methods, 
2002, 48, 117‐126. 
41.  T. Mossmann, Journal of Immunological Methods, 1983, 65, 55‐63. 
42.  D. Lobner, Journal of Neuroscience Methods, 2000, 96, 147‐152. 
43.  J. Wörle‐Knirsch, a. Pulskamp, K. Pulskamp and H. Krug, 2006, 1‐8. 
44.  A. M. Alkilany and C. J. Murphy, Journal of Nanoparticle Research, 2010, 1‐21. 
45.  J. Khan, B. Pillai, Taposh, Y. Singh and S. Maiti, ChemBioChem, 2007, 8, 1237‐1240. 
46.  A. Alkilany, S. C. Columbia, P. Nagaria, C. Hexel, T. Shaw, C. Murphy and M. Wyatt, Small, 
2009, 5, 701‐708. 
47.  R. Bilton and A. Woods, FEBS Letters, 1999, 449, 255‐258. 
48.  Ramos, R. Mateos, L. Bravo and L. Goya, Journal of Biochemical and Molecular 
Toxicology, 2005, 19, 119‐128. 
49.  S. R. Subramaniam and E. M. Ellis, Toxicology and Applied Pharmacology, 2011, 250, 
130‐136. 
 
 
